Additionally, mutations of the Cell Division Cycle 73 (CDC73) [100] tumor-suppressor gene (previously known as HRPT2) are associated with the Hyperparathyroidism-Jaw Tumor (HPT-JT) syndrome, an autosomal dominant disease whose clinical manifestations are mainly parathyroid tumors and, less frequently, ossifying fibromas of the jaw, as well as uterine and renal tumors. Here, CDC73 is linked to ossifying fibroma of the jaw.